Equity Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan

The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segments were as follows (in thousands):

	For the Three Months Ended March 31,
	2019		2018
Restricted stock / units	$	841	$	908
Performance shares / units	465		631
Non-qualified and performance stock options	124		227
Total stock-based compensation expense	$	1,430	$	1,766

Schedule of Unrecognized Compensation Cost, Nonvested Awards

As of March 31, 2019, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):

	March 31, 2019
Restricted stock and restricted stock units	$	13,900
Performance shares and performance share units	12,702
Non-qualified and performance stock options	1,815
Total unrecognized stock-based compensation expense	$	28,417

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes information about stock option activity for the three months ended March 31, 2019:

	March 31, 2019				Weighted Average Exercise Price
Options outstanding at January 1, 2019	1,885,362				$	18.78
Granted	—				—
Exercised	—				—
Canceled	(11,908		)		20.57
Options outstanding at March 31, 2019	1,873,454				$	18.77
Options exercise price range at March 31, 2019	$	12.15		to	$	33.36
Options exercisable at March 31, 2019	1,342,294
Shares available for grant at March 31, 2019*	687,667

________

 * Shares available for grant as of March 31, 2019 reduced by net restricted stock and restricted stock unit award activity of (246,070) shares and performance share and performance share unit award activity of 812,396 shares

Schedule of Share-based Compensation, Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2019:

	Options Outstanding				Options Exercisable
Exercise Prices	Number Outstanding at March 31, 2019	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price		Number Exercisable at March 31, 2019	Weighted Average Exercise Price
$ 12.15 – $20.00	801,734	6.5	$	12.77	270,574	$	14.00
$ 20.01 – $25.00	724,251	1.3	22.20		724,251	22.20
$ 25.01 – $30.00	342,973	1.4	25.33		342,973	25.33
$ 30.01 – $33.36	4,496	2.1	33.36		4,496	33.36
Total	1,873,454	3.5	$	18.77	1,342,294	$	21.38

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of options granted is estimated on the date of grant using a Black-Scholes option-pricing model. The calculated fair value of the 2017 performance option awards was $5.38 per option.

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):

	March 31, 2019		Weighted Average Fair Value
Stock / Units unvested at January 1, 2019	637,663		$	15.04
Granted	799,011		9.96
Vested	(10,000	)	15.68
Canceled	(46,960	)	14.56
Stock / Units unvested at March 31, 2019	1,379,714		$	12.11

Share-based Compensation, Performance Shares Award Unvested Activity

The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):

	March 31, 2019	Weighted Average Fair Value
Shares / Units unvested at January 1, 2019	448,294	$	14.37
Granted	576,737	9.93
Vested	—	—
Canceled	—	—
Shares / Units unvested at March 31, 2019	1,025,031	$	11.87